This week’s episode will be focusing on one of the GI plenary session abstracts presented at the ASCO Annual Meeting 2025, the MATTERHORN trial: phase 3 durvalumab + FLOT which is 5FU leucovorin, oxaliplatin and docetaxel in resectable gastric or GE junction CA.
Nov 10
Urothelial ESMO 2025 Updates
<p>This week’s episode will be on many exciting updates were announced at ESMO this October in Berlin from Oct 17-21, 2025, especially in bladder cancer, we continue to make such progress! We discuss key trials in NMIBC (POTOMAC), MIBC (KN-905, IMvigor-011), and metastatic urothe ... Show More
13m 11s
Oct 2024
2024 NCS Annual Meeting Recap
2024 NCS Annual Meeting RecapSpecial Guests: Andy Webb, PharmD, BCCCPKeaton Smetana, PharmD, MBA, FNCS, FCCM Recapping the 2024 Neurocritical Care Society Annual Meeting with Keaton Smetana and Andy Webb. PharmacyToDose.Com@PharmacyToDosePharmacyToDose@Gmail.com Learn more about ... Show More
1h 24m